Login / Signup
Ryan Thaliffdeen
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 3
Top Topics
Combination Therapy
Stem Cells
Decision Making
Top Venues
Clinical drug investigation
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Ryan Thaliffdeen
,
Anthony Yu
,
Karen L Rascati
Cost-Effectiveness Evaluation of Oral CGRP Antagonists, Atogepant and Rimegepant, for the Preventative Treatment of Episodic Migraine: Results from a US Societal Perspective Model.
Clinical drug investigation
44 (3) (2024)
Ryan Thaliffdeen
,
Anthony Yu
,
Karen L Rascati
Cost-Effectiveness Evaluation of Oral CGRP Antagonists, Atogepant and Rimegepant, for the Preventative Treatment of Episodic Migraine: Results from a US Societal Perspective Model.
Clinical drug investigation
(2024)
Ryan Thaliffdeen
,
Anthony Yu
,
Karen L Rascati
Cost-Effectiveness Evaluation of Oral CGRP Antagonists, Atogepant and Rimegepant, for the Preventative Treatment of Episodic Migraine: Results from a US Societal Perspective Model.
Clinical drug investigation
44 (3) (2024)